
Cyteir Therapeutics
Developing the next generation of synthetic lethal therapies to treat cancer.
Market cap
$108m
Enterprise value
($21m)
Share price
$3.01 CYT
Authorizing premium user...
Developing the next generation of synthetic lethal therapies to treat cancer.